Drug | Company | Purpose | Date |
Zubsolv®. Zubsolv® (buprenorphine and naloxone) | Orexo AB | treatment of opioid dependence | July 2013 |
Vivitrol® extended-release naltrexone | Alkermes | prevention of relapse to opioid dependence | October 2010 |
Vivitrol® Naltrexone | Alkermes | treatment of alcohol dependence | April 2006 |
CHANTIX® (varenicline), | Pfizer | treatment of nicotine addiction | May 2006 |
acamprosate calcium | Campral | treatment of alcoholism | 2004 |
Suboxone® (buprenorphine/naloxone) Subutex® (buprenorphine) | Reckitt Benckiser | treatment of opiate dependence | October 2002 |
NicoDerm CQ ® Nicorette® | Glaxo-SmithKline | for smoking cessation |
|
Naltrexone Hydrochloride oral tablets | Dupont | tablet form (50 mg taken daily) for the treatment of alcoholism | 1994 |
Antabuse® (disulfiram) | Odyssey Pharmaceuticals | Treatment of alcohol dependence | 1951 |